OG
Insider
Ori Gutwerg
SVP, GENERICSOri Gutwerg (SVP, GENERICS) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $243K of ANIP (3,162 sh × $77.00, as filed), executed Aug 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$621K
shares × price, as filed
Last traded
Aug 10
Filed Aug 11
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$243K3,162 sh × $77.00
Exec Aug 10
Filed Aug 11 · 8:57 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $220K
2,772 sh × $79.50
Exec May 12
Filed May 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $158K
2,060 sh × $76.50
Exec Mar 3
Filed Mar 4 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $508K
5,873 sh × $86.53
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $305K
5,084 sh × $60.00
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET